Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 78.01T 72.06T 65.3T 1L 82.92L 1L 9L 3L 43.45L 3L 3L 1.37Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 22Cr 20Cr 18Cr 34Cr 2.33TCr 35Cr 243.95Cr 97Cr 1.22TCr 92Cr 90Cr 3.85TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-2.54%+1.31%+54.27%+114.96% 1,13500Cr
-1.42%+3.23%+38.56%+74.44% 64TCr
+0.16%+0.08%+25.29%+95.23% 50TCr
-0.31%+3.09%+44.14%+64.80% 38TCr
-1.34%-0.47%+66.04%+41.00% 36TCr
-0.68%+2.65%+22.98%+50.39% 29TCr
-1.20%+3.04%+2.33%+22.86% 27TCr
-1.79%+1.57%+50.56%+59.08% 24TCr
-0.73%-0.10%+29.02%+99.67% 19TCr
Average -0.98%+1.95%+37.02%+69.16% 40.04TCr
Weighted average by Cap. -1.35%+2.66%+41.02%+79.75%

Financials

2016 2017
Net sales 5.43Cr 4.85Cr 4.48Cr 4.06Cr 7.59Cr 515.18Cr 7.72Cr 54Cr 21Cr 269.92Cr 20Cr 20Cr 850.99Cr 11Cr 9.46Cr 8.74Cr 7.92Cr 15Cr 1.01TCr 15Cr 105.18Cr 42Cr 526.95Cr 40Cr 39Cr 1.66TCr
Net income -10Cr -9.2Cr -8.5Cr -7.7Cr -14Cr -977.56Cr -15Cr -102.23Cr -40Cr -512.18Cr -39Cr -38Cr -1.61TCr -13Cr -11Cr -10Cr -9.36Cr -18Cr -1.19TCr -18Cr -124.29Cr -49Cr -622.73Cr -47Cr -46Cr -1.96TCr
Net Debt 21Cr 19Cr 17Cr 16Cr 29Cr 1.99TCr 30Cr 207.97Cr 82Cr 1.04TCr 79Cr 77Cr 3.29TCr 25Cr 22Cr 20Cr 18Cr 34Cr 2.33TCr 35Cr 243.87Cr 97Cr 1.22TCr 92Cr 90Cr 3.85TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock